Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2011 (2011), Article ID 370374, 3 pages
http://dx.doi.org/10.1155/2011/370374
Editorial

Immunologic Monitoring of Cellular Immune Responses in Cancer Vaccine Therapy

1Department of Pathology, University of Pittsburgh School of Medicine and University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213-1863, USA
2Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
3Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA

Received 7 April 2011; Accepted 7 April 2011

Copyright © 2011 Theresa L. Whiteside et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Vergati, V. Cereda, R. A. Madan et al., “Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination,” Cancer Immunology, Immunotherapy, vol. 60, no. 2, pp. 197–206, 2011. View at Publisher · View at Google Scholar · View at PubMed
  2. J. L. Gulley, P. M. Arlen, R. A. Madan et al., “Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer,” Cancer Immunology, Immunotherapy, vol. 59, no. 5, pp. 663–674, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. P. Filipazzi, R. Valenti, V. Huber et al., “Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine,” Journal of Clinical Oncology, vol. 25, no. 18, pp. 2546–2553, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. S. Vuk-Pavlović, P. A. Bulur, YI. Lin et al., “Immunosuppressive CD14+HLA-DR monocytes in prostate cancer,” Prostate, vol. 70, no. 4, pp. 443–455, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. N. Koide, A. Nishio, T. Sato, A. Sugiyama, and S. I. Miyagawa, “Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus,” American Journal of Gastroenterology, vol. 99, no. 9, pp. 1667–1674, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. T. Hanada, M. Nakagawa, A. Emoto, T. Nomura, N. Nasu, and Y. Nomura, “Prognostic value of tumor-associated macrophage count in human bladder cancer,” International Journal of Urology, vol. 7, no. 7, pp. 263–269, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Ohno, Y. Ohno, N. Suzuki et al., “Correlation of histological localization of tumor-associated macrophages with clinicopathological features in endometrial cancer,” Anticancer Research, vol. 24, no. 5, pp. 3335–3342, 2004. View at Google Scholar · View at Scopus
  8. B. C. Zhang, J. Gao, J. Wang, Z. G. Rao, B. C. Wang, and J. F. Gao, “Tumor-associated macrophages infiltration is associated with peritumoral lymphangiogenesis and poor prognosis in lung adenocarcinoma,” Medical Oncology. View at Publisher · View at Google Scholar · View at PubMed
  9. L. Butterfield, A. Palucka, C. Britten et al., “Recommendations from the iSBTc-SITC/FDA/NCI workshop on immunotherapy biomarkers,” Clinical Cancer Research, vol. 17, no. 10, pp. 3064–3076, 2011. View at Google Scholar